Cargando…
Adrenocortical Carcinoma and Synchronous Malignancies
Objective: Adrenocortical carcinoma (ACC) is an aggressive tumor that accounts for 0.02% of all reported cancers. ACC commonly arises in a sporadic manner, but may also manifest as part of a familial syndrome. Regardless of the setting, ACC rarely arises concurrent with other malignant tumors. Metho...
Autores principales: | Guerrero, Marlon A., Kebebew, Electron |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938073/ https://www.ncbi.nlm.nih.gov/pubmed/20842232 |
Ejemplares similares
-
SUN-349 Prognostic Metabolic Signature in Aggressive Adrenocortical Carcinoma
por: Tirosh, Amit, et al.
Publicado: (2019) -
Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors
por: Gara, Sudheer Kumar, et al.
Publicado: (2018) -
A rare case of synchronous adrenocortical carcinoma and renal cell carcinoma
por: Majhi, Urmila, et al.
Publicado: (2011) -
Was It an Adrenocortical Adenoma or an Adrenocortical Carcinoma? Limitation of the Weiss Scoring System in Determining the Malignant Potential of Adrenocortical Tumor: Report on Two Cases
por: Wong, Cheuk-Lik, et al.
Publicado: (2022) -
Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response
por: Nilubol, Naris, et al.
Publicado: (2018)